| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |